Public Workshop “Navigating CDER: What You Should Know for Effective Engagement- Drug Information Update

The Division of Drug Information (DDI)- serving the public by providing information on human drug products and drug product regulation by FDA.

The Food and Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER) will hold an upcoming workshop for advocacy groups and the public entitled “Roadmap for Engaging with FDA’s Center for Drug Evaluation and Research.”  The purpose of this workshop is to help the public learn how to successfully engage with FDA’s Center for Drug Evaluation and Research (CDER).

This public workshop will be held on May 12, 2017, from 9 a.m. to 3 p.m. EDT, at FDA’s White Oak campus in the Great Room. We invite you to sign-up to attend the workshop in person or by webcast. For more information about this public workshop please visit the workshop website. To register for the event click here.

The Notice of Availability posted in the Federal Register also provides additional information about the workshop.